Clearer information for your next medical decision.One careful step at a time.
05 · LAW & REGULATION

Regenerative medicine and legal systems

The Act on the Safety of Regenerative Medicine, cell-processing management, and provider plans, organized from a patient's viewpoint.

Regulatory information as material for safety thinking

The regulatory pages carry materials on aseptic operation, cell storage, provision-plan templates, and quality and safety evaluation of processed cell products. Systems are frameworks for conducting research and care safely.

Having procedures and having a treatment that is effective and safe for you are separate matters. Never take legal or notification status as proof of effect.

Beware the amended act and old wording

The official site notes the amended act took effect on May 31, 2025, and older wording may remain in materials. Check creation and revision dates with wording definitions, and cross-check current MHLW and PMDA information.

What patients can ask

You can ask which law and system the offer falls under, whether it is research or care, whether explanatory and consent documents exist, what is observed after treatment and where, and where to contact in emergencies. If answers stay vague while you are rushed to sign, take materials home and consult another clinician.

Official information and references

JSRM: Regulatory information ↗

MHLW: Regenerative medicine ↗